alexander j. freiman, mph, cph cdc/cste applied epidemiology fellow
DESCRIPTION
Case-Control Investigation of a Drug-Resistant Acinetobacter baumannii Outbreak at a Regional Medical Center in Eastern Kentucky, 2010. Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow Kentucky Department for Public Health June 15, 2011. Background. A. baumannii - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/1.jpg)
1
Case-Control Investigation of a Drug-Resistant
Acinetobacter baumannii Outbreak at a Regional
Medical Center in Eastern Kentucky, 2010
Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology
FellowKentucky Department for Public
HealthJune 15, 2011
![Page 2: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/2.jpg)
2
Background A. baumannii
Aerobic, gram negative bacteria Persist in environment Person-person or direct contact Drug resistance
Outbreaks of multi drug-resistant (MDR) A. baumannii in healthcare setting a growing concern Healthcare-associated infection Especially in intensive care units (ICUs)
![Page 3: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/3.jpg)
3
Background Kentucky Department for Public
Health (KDPH) notified of Acinetobacter outbreak in September, 2010 66 cases initially reported
Assistance requested from KDPH New Infection Preventionist Reported gaps in infection control
process Hand hygiene Lacked comprehensive environmental
cleaning protocols
![Page 4: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/4.jpg)
4
Background Response team assembled from
KDPH and began on-site evaluation CDC collaboration
Medical epidemiologist Laboratory experts
![Page 5: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/5.jpg)
5
Objectives Two main objectives
Identify risk factors associated with recovery of A. baumannii in hospitalized ICU patients
Investigate potential environmental sources of A. baumannii in healthcare facility
![Page 6: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/6.jpg)
6
Methods Study Design
Case-control Case definition:
Laboratory-confirmed cultures of MDR A. baumannii ≥72 hours after hospital admission
ICU admission January-September 2010
![Page 7: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/7.jpg)
7
Methods Control definition
ICU admission December 2009-October 2010 No history of A. baumannii infection in
chart Controls were matched to cases 1:1
ICU admission date ICU length of stay
![Page 8: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/8.jpg)
8
Methods Abstracted information from medical
records Demographics Admission/discharge Medical history Laboratory results Consultations Procedures Medications
![Page 9: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/9.jpg)
9
Methods Statistical Analysis
Frequencies T-test, Chi square test, Fisher’s exact
test Odds ratios between potential risk
factors and MDR A. baumannii recovery using logistic regression
Univariate Multivariate
Conducted using SPSS software
![Page 10: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/10.jpg)
10
Methods Collected environmental samples
using wide sponge culturettes Site selection
High touch surfaces in areas with infected patients
Identified in previous studies CDC recommendations
![Page 11: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/11.jpg)
11
Methods One sample taken at each of five
sites ICU glucometer ICU medication dispensing unit ICU nursing station digital camera Portable x-ray machine Countertops in radiology unit
![Page 12: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/12.jpg)
12
Methods Five environmental and three
patient samples sent to state and CDC labs for pulsed field gel electrophoresis (PFGE) typing
Similarity between strains from environmental and patient samples determined using computer software
![Page 13: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/13.jpg)
13
Case Selection
![Page 14: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/14.jpg)
14
Case Selection
![Page 15: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/15.jpg)
15
Case Selection
![Page 16: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/16.jpg)
16
Case Selection
![Page 17: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/17.jpg)
17
Results
Jan Feb Mar Apr May Jun Jul Aug Sep02468
10
Epidemic curve for MDR A. baumannii cases in an eastern Kentucky regional
medical center, 2010 (N=30)
Month
Num
ber
of c
ases
![Page 18: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/18.jpg)
18
ResultsSelected Characteristics of Cases and Controls
Characteristic Casen (%)
Controln (%) P value
Race/EthnicityCaucasian 29 (97) 29 (97) 1.00Non-Hispanic 29 (97) 29 (97) 1.00
Age (in years)Mean 68 67 0.72Median 70 69Range 40-87 38-105
SexFemale 12 (40) 17 (57) 0.30
ComorbidityDiabetes 18 (60) 10 (33) 0.04
![Page 19: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/19.jpg)
19
Results
Source of MDR A. baumannii culture from cases (N=30)
Source n (%)Respiratory 19 (63)Blood 5 (17)Wound 4 (13)Urine 2 (7)
![Page 20: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/20.jpg)
20
Results
Environmental culture results Site ResultPortable x-ray machine PositiveICU nursing station digital camera
Positive
ICU medication dispensing unit NegativeICU glucometer NegativeCountertops in radiology unit Negative
![Page 21: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/21.jpg)
21
Results
Patient 4 from another healthcare facility
*
*
![Page 22: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/22.jpg)
22
Results
Patient 4 from another healthcare facility
*
*
![Page 23: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/23.jpg)
23
Results
Patient 4 from another healthcare facility
*
*
![Page 24: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/24.jpg)
24
Results
Patient 4 from another healthcare facility
*
*
![Page 25: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/25.jpg)
25
ResultsCrude Associations for Risk Factors and Positive MDR
A. baumannii CultureRisk Factors OR P value 95% Confidence IntervalReceived subcutaneous or intravenous insulin 4.97 0.014* (1.39, 17.82)Fingersticks performed 5.02 0.025* (1.23, 20.49)Total number of chest x-ray procedures 1.10 0.032* (1.01, 1.21)Diabetic 3.00 0.041* (1.05, 8.60)Central line performed 3.14 0.043* (1.03, 9.55)Decubitis ulcer present 2.62 0.072 (0.92, 7.46)Consulted with occupational therapist 3.08 0.094 (0.82, 11.50)Did patient have cardiovascular issues 3.27 0.107 (0.77, 13.83)Obese 2.41 0.111 (0.82, 7.10)*p value ≤ 0.05
![Page 26: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/26.jpg)
26
ResultsCrude Associations for Risk Factors and Positive MDR
A. baumannii CultureRisk Factors OR P value 95% Confidence IntervalReceived subcutaneous or intravenous insulin
4.97 0.014* (1.39, 17.82)
Fingersticks performed 5.02 0.025* (1.23, 20.49)Total number of chest x-ray procedures 1.10 0.032* (1.01, 1.21)Diabetic 3.00 0.041* (1.05, 8.60)Central line performed 3.14 0.043* (1.03, 9.55)Decubitis ulcer present 2.62 0.072 (0.92, 7.46)Consulted with occupational therapist 3.08 0.094 (0.82, 11.50)Did patient have cardiovascular issues 3.27 0.107 (0.77, 13.83)Obese 2.41 0.111 (0.82, 7.10)*p value ≤ 0.05
![Page 27: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/27.jpg)
27
ResultsCrude Associations for Risk Factors and Positive MDR
A. baumannii CultureRisk Factors OR P value 95% Confidence IntervalReceived subcutaneous or intravenous insulin 4.97 0.014* (1.39, 17.82)Fingersticks performed 5.02 0.025* (1.23, 20.49)Total number of chest x-ray procedures 1.10 0.032* (1.01, 1.21)Diabetic 3.00 0.041* (1.05, 8.60)Central line performed 3.14 0.043* (1.03, 9.55)Decubitis ulcer present 2.62 0.072 (0.92, 7.46)Consulted with occupational therapist 3.08 0.094 (0.82, 11.50)Did patient have cardiovascular issues 3.27 0.107 (0.77, 13.83)Obese 2.41 0.111 (0.82, 7.10)*p value ≤ 0.05
![Page 28: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/28.jpg)
28
ResultsAdjusted Associations for Risk Factors and MDR
A. baumannii Culture for Sampled EquipmentRisk Factors OR P value 95% Confidence IntervalFingersticks performed* 4.34 0.048 (1.01, 18.62)Total number of chest x-ray procedures† 1.10 0.065 (0.99, 1.22)Decubitis ulcer photographed* 2.71 0.083 (0.88, 8.37)*Model adjusted for age, type of admission, and mechanical ventilation†Model adjusted for age, type of admission, and fingersticks
![Page 29: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/29.jpg)
29
ResultsAdjusted Associations for Risk Factors and MDR
A. baumannii Culture for Sampled EquipmentRisk Factors OR P value 95% Confidence IntervalFingersticks performed* 4.34 0.048 (1.01, 18.62)Total number of chest x-ray procedures† 1.10 0.065 (0.99, 1.22)Decubitis ulcer photographed* 2.71 0.083 (0.88, 8.37)*Model adjusted for age, type of admission, and mechanical ventilation†Model adjusted for age, type of admission, and fingersticks
![Page 30: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/30.jpg)
30
Discussion Lab cultures identified two possible
sources for MDR A. baumannii transmission to patients in the facility Portable chest x-ray machine Digital camera used for wound
photography PFGE pattern similarity between
environmental and patient samples matched between 92-100%
![Page 31: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/31.jpg)
31
Discussion Epidemiologic analysis suggests
receiving fingersticks is a risk factor for becoming a case
Breakdowns in disease prevention activities Hand hygiene Cleaning shared equipment
Lack of clear equipment-cleaning responsibility might have contributed to ongoing transmission
![Page 32: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/32.jpg)
32
Discussion Limitations
Generalizability Small sample
Reliability Cases: Controls only 1:1
Validity Lack of true electronic medical records Incomplete line listing from healthcare
facility
![Page 33: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/33.jpg)
33
Discussion Have procedures in place to clean all
shared equipment Recognition of an outbreak and
immediate implementation of effective controls is CRITICAL to preventing MDR A. baumannii transmission in the healthcare setting
![Page 34: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/34.jpg)
34
AcknowledgmentsKentucky Department for Public HealthMargaret A. Riggs, PhD, MPH, MAFontaine Sands, DrPH, MSN, CICDavid R. Reese, MA, MPH, FRSPHKraig E. Humbaugh, MD, MPHDoug Thoroughman, PhD, MSRobert L. Brawley, MD, MPH, FSHEA
Centers for Disease Control and Prevention, Division of Healthcare Quality and PromotionAlexander J. Kallen, MD, MPHJudith Noble-Wang, PhDHeather A. O’Connell, PhD
![Page 35: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/35.jpg)
35
Acknowledgments This study was supported in part by
an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists (CSTE) and funded by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement Number 5U38HM000414.
![Page 36: Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow](https://reader035.vdocuments.mx/reader035/viewer/2022081502/56815df8550346895dcc2da4/html5/thumbnails/36.jpg)
36
Contact InformationAlex Freiman
CDC/CSTE Applied Epidemiology Fellow
Kentucky Department for Public Health
Phone: (502)564-3261 x3278Email: [email protected]